乳腺癌管理的进展与挑战：一部由演进与变革构成的历史。
Advances and Challenges in Breast Cancer Management: A History Made of Evolutions and Revolutions.
作者信息
Belkacemi Yazid
机构信息
Department of Radiation Oncology and Henri Mondor Breast Center, Henri Mondor University Hospital, (APHP), University of Paris Est Créteil (UPEC), INSERM Unit 955 (i-Bio), Institut Mondor dec Recherche Biomédicale (IMRB), 94010 Creteil, France.
出版信息
Cancers (Basel). 2023 Mar 10;15(6):1713. doi: 10.3390/cancers15061713.
Abstract
Jean Jaurès (1859-1914) stated that "Human history is but a ceaseless effort of invention, and perpetual evolution and creation" [...].
摘要
让·饶勒斯（1859 - 1914）曾说过：“人类历史不过是一场不断的发明努力，以及持续的进化与创造”[...]。
相似文献
1
Advances and Challenges in Breast Cancer Management: A History Made of Evolutions and Revolutions.乳腺癌管理的进展与挑战：一部由演进与变革构成的历史。
Cancers (Basel). 2023 Mar 10;15(6):1713. doi: 10.3390/cancers15061713.
2
Surgical revolutions.外科革命
J Invest Surg. 2008 Jul-Aug;21(4):165-8. doi: 10.1080/08941930802255573.
3
On Evolutions and Revolutions in Emergency Care: Commemorating the Emergency Nurses Association's 50th Anniversary.论急诊护理的演变与变革：纪念急诊护士协会成立50周年
J Emerg Nurs. 2020 Jan;46(1):2-7. doi: 10.1016/j.jen.2019.11.009.
4
Editorial: Spinal Muscular Atrophy: Evolutions and Revolutions of Modern Therapy.社论：脊髓性肌萎缩症：现代疗法的演进与变革
Front Neurol. 2020 Jul 28;11:783. doi: 10.3389/fneur.2020.00783. eCollection 2020.
5
Hot Topics of the Past Decade: Evolutions and Revolutions in Lower Urinary Tract Symptoms.过去十年的热点话题：下尿路症状的演变与革命。
Eur Urol Focus. 2022 Mar;8(2):371-374. doi: 10.1016/j.euf.2022.03.012. Epub 2022 Apr 7.
6
Baron Jean-Louis Alibert (1768-1837) and the first description of mycosis fungoides.让 - 路易·阿利贝尔男爵（1768 - 1837）与蕈样肉芽肿的首次描述。
J BUON. 2014 Apr-Jun;19(2):585-8.
7
Evolutions and revolutions in practice: so what's new?实践中的演变与变革：那么有什么新情况呢？
J Prof Nurs. 1986 May-Jun;2(3):140, 197-8. doi: 10.1016/s8755-7223(86)80056-4.
8
[Evolutions and revolutions in periodontology. A report on the 23rd Annual Meeting of the Swiss Society for Periodontology of 16-18 September 1993 in Interlaken].[牙周病学的发展与变革。1993年9月16日至18日在因特拉肯举行的瑞士牙周病学会第23届年会报告]
Schweiz Monatsschr Zahnmed. 1993;103(11):1480-3, 1518-20.
9
Jean-Louis Petit (1674-1750): a pioneer anatomist and surgeon and his contribution to orthopaedic surgery and trauma surgery.让 - 路易·佩蒂（1674 - 1750）：一位解剖学家和外科医生先驱及其对骨科手术和创伤外科的贡献。
Int Orthop. 2018 Aug;42(8):2003-2007. doi: 10.1007/s00264-018-3978-8. Epub 2018 May 11.
10
[The market at the heart of the invention of the museum ? : Jean-Baptiste-Pierre Lebrun at the Louvre (1792-1802)].[博物馆诞生核心之地的市场？：让 - 巴蒂斯特 - 皮埃尔·勒布伦在卢浮宫（1792 - 1802年）]
Rev Synth. 2011;132(1):93-117. doi: 10.1007/s11873-010-0142-z.
本文引用的文献
1
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.免疫疗法毒性的管理：ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2022 Dec;33(12):1217-1238. doi: 10.1016/j.annonc.2022.10.001. Epub 2022 Oct 18.
2
Editorial: Advancements in immunology and immunotherapy for breast cancer.社论：乳腺癌免疫学与免疫治疗的进展
Front Oncol. 2022 Aug 9;12:979806. doi: 10.3389/fonc.2022.979806. eCollection 2022.
3
[Oncogeriatric assessment: The first step in personalizing cancer treatment in the elderly].[老年肿瘤学评估：老年癌症个体化治疗的第一步]
Rev Med Interne. 2022 Mar;43(3):152-159. doi: 10.1016/j.revmed.2021.10.006. Epub 2021 Nov 23.
4
De-escalation of Endocrine Therapy in Early Hormone Receptor-positive Breast Cancer: When Is Local Treatment Enough?早期激素受体阳性乳腺癌内分泌治疗的降级：何时局部治疗足够？
Ann Surg. 2021 Oct 1;274(4):654-663. doi: 10.1097/SLA.0000000000005064.
5
Breast cancer: from "maximum tolerable" to "minimum effective" treatment.乳腺癌：从“最大限度耐受”到“最小有效”治疗。
Front Oncol. 2012 Oct 8;2:125. doi: 10.3389/fonc.2012.00125. eCollection 2012.
6
[Past, present and near future of techniques in radiation oncology].[放射肿瘤学技术的过去、现在与近期未来]
Bull Cancer. 2010 Jul;97(7):743-51. doi: 10.1684/bdc.2010.1142.
7
Concurrent trastuzumab--internal mammary irradiation for HER2 positive breast cancer: "It hurts to be on the cutting edge".曲妥珠单抗与内乳区放疗联合用于HER2阳性乳腺癌：“站在前沿很痛苦”
Radiother Oncol. 2010 Jan;94(1):119-20; author reply 120-1. doi: 10.1016/j.radonc.2009.04.009. Epub 2009 May 4.
8
Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study.HER2阳性乳腺癌患者中曲妥珠单抗与辅助放疗同时使用：来自法国多中心研究的急性毒性分析
Ann Oncol. 2008 Jun;19(6):1110-6. doi: 10.1093/annonc/mdn029. Epub 2008 Mar 15.
9
Trastuzumab in the treatment of breast cancer.曲妥珠单抗治疗乳腺癌
N Engl J Med. 2005 Oct 20;353(16):1734-6. doi: 10.1056/NEJMe058196.
10
Neoadjuvant therapy in cancer treatment.癌症治疗中的新辅助治疗。
Cancer. 1993 Dec 1;72(11 Suppl):3515-24. doi: 10.1002/1097-0142(19931201)72:11+<3515::aid-cncr2820721619>3.0.co;2-a.
Zotero 插件